News & Articles

Read this application note to discover how T cell activation assays can help accelerate COVID-19 vaccine development

The real-time PCR workflow has a capacity of up to 6,000 tests per day per system, and demonstrated 100% agreement with authorized nasopharyngeal assays

IgM assay has 95.51% positive predictive value even when disease incidence is only 3%

Leveraging GenMark’s eSensor XT-8 platform hopes to expand COVID-19 diagnostic testing capacity

Watch this on-demand webinar to learn all about the new alternative to live virus neutralization and immunoglobulin detection

Enables labs to quickly ramp up testing capacity and generate results faster

This powerful new solution aims to provide more accurate COVID-19 antibody detection

Join us on Monday, August 17, to discover solutions for your laboratory's SARS-CoV-2 testing

Join us on Wednesday, August 26, to learn about an alternative assay that aims to identify virus-neutralizing antibodies in as little as five hours

Just leave a quick lab product review today for your chance to scoop one of our weekly $100 prizes

With this numerical result expressed as index value, clinicians will be better equipped to evaluate the duration and level of an individual’s immune response

Dr. Nallasivam Palanisamy, Henry Ford Cancer Institute, discusses his discovery of the first pseudogene-associated recurrent gene fusion in cancer and the potential for this robust biomarker for application beyond prostate cancer

Developed with enhanced technology, this new assay provides high-quality staining with improved turnaround time

New assays for Campylobacter, STEC, Vibrio and Staphylococcus aureus enable more comprehensive pathogen testing for all food manufacturers

Dr. Clifton Ray discusses the potential of Nanotrap particles to advance extracellular vesicle research, and how his team is using them to break down barriers in isolation, screening, and disease diagnostics

AccuPlex™ SARS-CoV-2 Verification Panel and Reference Material Kit are now available with full SARS-CoV-2 viral genome coverage

Establishing a broad range of remotely accessible COVID-19 assays including biochemical profiling for COVID-19 drug targets

The bridging assay aims to allow a full-length trimeric Spike protein from the COVID-19 virus to be used as both a capture and detection tool

Dr. Emma Walker reveals how transitioning from immunoassays to LC-MS/MS has helped deliver better diagnostic services in her lab

Find out about the 'revolutionary' technology enabling one lab to provide higher-quality, more timely data for cancer researchers

Dr. Dennis Nurjadi discusses the cell counting technology that has brought his team accuracy and reproducibility

The panel will be bundled with an analysis platform from One Codex designed to enable an easy-to-use, complete end-to-end workflow that begins from the Twist target enrichment panel and continues through publication-ready visualizations

Researchers suggest cortisol levels can be used to identify those patients who are more likely to need intensive care